Novel microbiome-based therapeutics for chronic rhinosinusitis. - Wikidata - wikimedia - TriplyDB

Novel microbiome-based therapeutics for chronic rhinosinusitis.

Novel microbiome-based therapeutics for chronic rhinosinusitis.

http://www.wikidata.org/entity/Q35578935

about

A role for auto-immunity in chronic rhinosinusitis? Lessons learned from sub-epidermal bullous disorders of the skin The Airway Microbiome at Birth.KlebSeq, a Diagnostic Tool for Surveillance, Detection, and Monitoring of Klebsiella pneumoniae Chronic rhinosinusitis: the rationale for current treatments.Chronic Rhinosinusitis and the Evolving Understanding of Microbial Ecology in Chronic Inflammatory Mucosal Disease.Exploring the bacterial assemblages along the human nasal passage.Large-Scale Phylogenomics of the Lactobacillus casei Group Highlights Taxonomic Inconsistencies and Reveals Novel Clade-Associated Features.Clinical efficacy of a topical lactic acid bacterial microbiome in chronic rhinosinusitis: A randomized controlled trial.Modelling upper respiratory tract diseases: getting grips on host-microbe interactions in chronic rhinosinusitis using in vitro technologies.Recent advances in biologic therapy of asthma and the role in therapy of chronic rhinosinusitis.

P2860

Q28079094-2822B10B-2B9F-41DB-8D3F-CB71121BE555 Q37151241-B69B3FB8-398A-4C6E-9163-9BF48BD35D45 Q37280606-01D538D0-72D9-4006-9B94-C5F4CB0043BA Q38833522-9EEFB388-E254-440B-B4F6-0C39B58B9462 Q39024902-3A9862D6-9588-4457-91A9-611CDE5D31FC Q40665480-10F29FB1-C97E-4379-BFDE-41633895FB04 Q41486444-4B552CB2-CD00-4C4A-BB8C-6A54B9352AEA Q47106938-01C17B68-7ED3-49FC-97CA-2191BB7D5FF4 Q54940368-8AA8DBE9-14F4-4434-9A1B-FB942AA154B3 Q55311604-FFBE82A5-7D8E-4CA9-AA23-86DEDD4B3B19

P2860

Novel microbiome-based therapeutics for chronic rhinosinusitis.

http://www.wikidata.org/entity/Q35578935

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Novel microbiome-based therapeutics for chronic rhinosinusitis.

@ast

Novel microbiome-based therapeutics for chronic rhinosinusitis.

@en

type

label

Novel microbiome-based therapeutics for chronic rhinosinusitis.

@ast

Novel microbiome-based therapeutics for chronic rhinosinusitis.

@en

prefLabel

Novel microbiome-based therapeutics for chronic rhinosinusitis.

@ast

Novel microbiome-based therapeutics for chronic rhinosinusitis.

@en

P1433

Q35578935-FD9B8DB4-0045-4E62-9F22-30890E86DCA2

P1476

Q35578935-6491581F-6AF5-4D91-92E1-19E8E9A79EF3

P2093

Q35578935-4975D912-B746-40A6-BEB6-2086E4D3222D

Q35578935-8024C980-49F7-4FF8-A55D-C2E0EEE58A12

P2860

Q35578935-066055CD-9DC1-41F4-857F-986CC03CA693

Q35578935-0A4EEE0B-36C1-486E-B062-24A4C52CFE77

Q35578935-0FFAEB07-DE07-4E60-9B56-295B71CD6ADE

Q35578935-10EC6E38-3BFB-4995-8AB2-07B05EF5C01B

Q35578935-1142D47F-A662-451A-8CED-0F5F0E89C9D6

Q35578935-118E014E-69F4-41D1-9269-56D5BE200FC2

Q35578935-13F66C59-5D8F-41F4-B09C-8302368E8E84

Q35578935-176D3D3A-41B1-40E9-9D38-EA8E874569C3

Q35578935-17EB2F02-3102-48CF-AB6E-FC0C9F4FCA1C

Q35578935-1A308471-F0A2-4DBF-9D43-E79A8A2CA210

P2888

Q35578935-AA5B321F-0172-4FA7-B97D-206A9160C3B5

P304

Q35578935-3B559B15-AE39-4BF9-BB93-D33CE2A137D6

P31

Q35578935-AEF2F5F5-9CD0-4E12-BBE9-FB8873DC2757

P356

Q35578935-BBD0C789-492B-4A1B-9BE7-BC5425BC36C7

P433

Q35578935-86B453D8-472D-4D22-95D8-64CFC204B79B

P478

Q35578935-1F62558F-58B6-4EAC-AF63-C62CD24770CF

P577

Q35578935-DBE4C7B0-8784-4564-B3BB-DBD3E2C1D9D7

P698

Q35578935-EF487399-C71F-4175-BBE2-C5B97CFA305D

P921

Q35578935-580A97DD-21CB-4B76-AF8D-8C52BB9F0249

Q35578935-E0E98064-1B0E-489C-A089-4982B150F805

P356

S11882-014-0504-Y

P1433

Current Allergy and Asthma Reports

P1476

Novel microbiome-based therapeutics for chronic rhinosinusitis.

@en

P2093

E K Cope

http://www.w3.org/2001/XMLSchema#string

S V Lynch

http://www.w3.org/2001/XMLSchema#string

P2860

Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients

Disordered microbial communities in asthmatic airways

Moving pictures of the human microbiome

Compartmentalized control of skin immunity by resident commensals

Microbial exposure during early life has persistent effects on natural killer T cell function

Structure, function and diversity of the healthy human microbiome

Induction of intestinal Th17 cells by segmented filamentous bacteria

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

Duodenal infusion of donor feces for recurrent Clostridium difficile

P2888

s11882-014-0504-y

P304

504

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11882-014-0504-Y

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25777787

http://www.w3.org/2001/XMLSchema#string

P921